Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Nintedanib (ofev And Generics), Atc L01ex09 For The Period 01.05.2630 To 04.28 (plus Option 1x12 Months) 2026-09-13
Poland Fdzp.226.11.2026 Delivery Of Medical Apparatus And Equipment For The Cardiology Department 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Clindamycin (excluding Dafo Vsu), Atc G01aa10 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Fentanyl, Only Sublingual Tablets, Lozenges Or Nasal Spray, Atc N02ab03 2026-09-13
Finland Diagnostic Devices And Accessories Dps 2026-09-13
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Tolvaptan, Atc G04bx21 2026-09-13
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Eptinezumab, Atc N02cd05 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Moxifloxacin, Atc S01ae07 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Enalapril (without 2.5 Mg + 5 Mg), Atc C09aa02 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Germany Open House Pharmaceutical Discount Contracts Eptinezumab, Atc N02cd05 2026-09-13
Whats app